Plain-English translation of NCT06813079 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial uses a special laboratory technique to grow a tiny model of your pancreatic cancer tumor from your own tissue. Researchers then test different medications on this model to see which one works best against your cancer. If the testing shows that a particular medication is likely to be effective, you'll be offered the chance to take that medication as your treatment.
Pancreatic cancer is difficult to treat, and not every medication works the same way for every patient. This trial exists to find a smarter way to choose your treatment by testing medications directly against your tumor before you receive them, so you have the best chance of getting a therapy that's tailored to your specific cancer.
You likely qualify if…
You likely don't qualify if…
If you qualify for this study, you'll receive the personalized medication that was selected based on your tumor model testing. The study has two groups: one for people whose cancer is growing despite prior treatment, and one for people whose cancer is stable on current therapy. You'll need to visit the clinic for appointments to receive your medication, have blood tests, and be monitored for how well the treatment is working and any side effects you may experience.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Canada